卵巢子宫内膜异位囊肿导管定向硬化治疗技术结局的影响因素
回顾性分析2015年11月至2023年6月接受导管定向硬化治疗的323例患者共401个卵巢子宫内膜异位囊肿,技术成功率为94.0%(377/401),无重大并发症;多因素分析显示囊肿直径<3 cm、T2暗信号及经阴道途径是技术失败的独立危险因素。
要点
- 技术成功定义为7或8.5-French导管置入囊肿、内容物完全抽吸且硬化治疗完成无乙醇泄漏。
- 囊肿直径<3 cm、T2暗信号及经阴道途径与导管定向硬化治疗技术失败相关。
- 401个囊肿中377个(94.0%)技术成功,未观察到重大并发症。
核心结论
- 囊肿直径<3 cm、T2暗信号强度及经阴道途径被确定为导管定向硬化治疗过程中技术失败的显著危险因素。
研究设计与样本
- 回顾性研究纳入2015年11月至2023年6月接受导管定向硬化治疗的323例女性(平均年龄32.2±6.0岁)共401个卵巢子宫内膜异位囊肿;术前磁共振成像评估囊肿直径、形态(单房或多房)及T2信号强度,并分析导管尺寸(7或8.5-French)和入路(经腹部 vs 经阴道);采用多因素logistic回归分析确定与技术结局相关的因素。
关键影像表现/征象
- 术前磁共振成像评估囊肿直径、形态(单房或多房)及T2信号强度;T2暗信号强度与导管定向硬化治疗技术失败相关(比值比7.462;P=0.001)。
诊断标准与关键数值
- 技术成功定义为:1)将7或8.5-French导管置入子宫内膜异位囊肿;2)完全抽吸内部内容物;3)完成硬化治疗且无乙醇泄漏;401个囊肿中377个(94.0%)技术成功;多因素分析中,直径<3 cm(比值比25.641;P<0.001)、T2暗信号强度(比值比7.462;P=0.001)、经阴道途径(比值比4.016;P=0.004)与技术失败相关。
临床应用与阅片要点
- 对于囊肿直径<3 cm、T2暗信号强度或计划经阴道途径的卵巢子宫内膜异位囊肿患者,导管定向硬化治疗的技术失败风险较高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify factors related to technical outcomes of catheter-directed sclerotherapy (CDS) and suggest selection criteria for CDS in patients with ovarian endometrioma.
METHOD: This retrospective study included patients with endometriomas treated with CDS between November 2015 and June 2023. The characteristics of the endometriomas, including diameter, morphology (unilocular or multilocular), and T2 signal intensity were evaluated using pre-procedure magnetic resonance imaging. Moreover, the size of the catheter (7- or 8.5-French) and route of access (transabdominal vs. transvaginal) was also analyzed. Multivariate logistic regression analyses were used to identify factors associated with the technical outcomes of CDS.
RESULTS: Technical success was defined as successful completion of the following: 1) insertion of a 7- or 8.5-French catheter into the endometrioma, 2) full aspiration of the internal content, and 3) completion of sclerotherapy without ethanol leakage. Of the 323 women (mean age = 32.2 ± 6.0 years) with 401 endometriomas included in our study, technical success was achieved in 377 endometriomas (94.0 %). No major complications were observed. In the multivariate analysis, a diameter < 3 cm (odds ratio, 25.641; p < 0.001), T2 dark signal intensity (odds ratio, 7.462; p = 0.001), and transvaginal access (odds ratio, 4.016; p = 0.004) were associated with technical failure.
CONCLUSIONS: Small endometrioma size (<3cm), T2 dark signal intensity, and transvaginal access were identified as significant risk factors for technical failure during catheter-directed sclerotherapy.
引用
- Kim DK, Seo SK, Han K, et al. Factors affecting the technical outcome of catheter-directed sclerotherapy for ovarian endometriomas. Eur J Radiol. 2024. PMID: 39393214. doi:10.1016/j.ejrad.2024.111773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。